Report from the 13th Retrovirus Conference

This year’s Retrovirus Conference was held in downtown Denver at the sparkling new Colorado Convention Center. The sheer size of the site was a far cry from the original meetings 13 years ago, which took place in a much more intimate Washington, DC, hotel, but the increased scale of the meeting has only solidified it as the leading venue for presenting HIV-related research to both clinical and basic-science audiences.

As always, the focus of our meeting report is on new study results that could have an immediate and direct effect on HIV clinical care. All abstracts, as well as webcasts of the symposia, are available at the meeting website: www.retroconference.org. — Paul E. Sax, MD

Both Merck and Gilead have inv…